Clinical Trial Update: Iadademstat + SBRT With Atezo in ES-SCLC [Phase 1]

View source ↗

Summary

Phase 1 study evaluating iadademstat in combination with SBRT and atezolizumab for extensive-stage small cell lung cancer; recruitment is ongoing at Yale Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Iadademstat (iadademstat)

Snippet

Sponsor: Yale University | Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 1 | Status: RECRUITING